Tudor Investment Corp
SLDB icon

Tudor Investment Corp’s Solid Biosciences SLDB Stock Holding History

Tudor Investment Corp’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,607
Closed -$216K – 1909
2021
Q1 		$216K Buy
+2,607
New +$288K ﹤0.01% 1405
2020
Q4 		– Sell
-1,301
Closed -$40K – 1606
2020
Q3 		$40K Sell
1,301
-197
-13% -$7.54K ﹤0.01% 1222
2020
Q2 		$66K Sell
1,498
-346
-19% -$14.4K ﹤0.01% 1099
2020
Q1 		$66K Sell
1,844
-167
-8% -$8.26K 0.01% 957
2019
Q4 		$134K Buy
+2,011
New +$222K 0.01% 1040
2019
Q3 		– Sell
-1,504
Closed -$130K – 1313
2019
Q2 		$130K Buy
+1,504
New +$164K ﹤0.01% 1015

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Tudor Investment Corp's SLDB Position: Q2 2021 in Review

Tudor Investment Corp sold out of Solid Biosciences (SLDB) in Q2 2021, closing a stake of 2,607 shares — an estimated $216K sold.

Tudor Investment Corp first reported a position in SLDB in Q2 2019 and held it in 6 quarters. The position peaked at $216K in Q1 2021. 92 funds tracked by Wall St. Rank hold SLDB as of Q2 2021.

  • Tudor Investment Corp reported no remaining Solid Biosciences position as of Q2 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 2,607 Solid Biosciences shares in Q2 2021, an estimated $216K.
  • Tudor Investment Corp first reported a position in Solid Biosciences in Q2 2019 and held it in 6 quarters.
  • Tudor Investment Corp's Solid Biosciences position peaked at $216K in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.